{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:20:16Z","timestamp":1776406816519,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.ejim.2012.10.008","type":"journal-article","created":{"date-parts":[[2012,11,20]],"date-time":"2012-11-20T12:48:27Z","timestamp":1353415707000},"page":"145-150","source":"Crossref","is-referenced-by-count":3,"title":["Prehospital statin therapy and one-year mortality in patients with stable coronary artery disease undergoing percutaneous coronary intervention"],"prefix":"10.1016","volume":"24","author":[{"given":"Gjin","family":"Ndrepepa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamin","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Cassese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Fusaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Sch\u00f6mig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2012.10.008_bb0005","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/01.CIR.0000037520.89770.5E","article-title":"Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction","volume":"106","author":"Herrmann","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.10.008_bb0010","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/hc0602.103586","article-title":"Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention","volume":"105","author":"Chan","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.10.008_bb0015","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","article-title":"Heart disease and stroke statistics\u20142012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.10.008_bb0020","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(08)61244-1","article-title":"Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial","volume":"372","author":"Windecker","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2012.10.008_bb0025","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/01.CIR.0000137828.06205.87","article-title":"Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study","volume":"110","author":"Pasceri","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.10.008_bb0030","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jacc.2009.05.028","article-title":"Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial","volume":"54","author":"Di Sciascio","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2012.10.008_bb0035","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.ehj.2004.07.017","article-title":"Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction","volume":"25","author":"Briguori","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2012.10.008_bb0040","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.jacc.2009.07.005","article-title":"Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction","volume":"54","author":"Briguori","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2012.10.008_bb0045","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1253\/circj.71.1225","article-title":"Randomized trial of statin administration for myocardial injury: is intensive lipid-lowering more beneficial than moderate lipid-lowering before percutaneous coronary intervention?","volume":"71","author":"Kinoshita","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.ejim.2012.10.008_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10557-010-6224-1","article-title":"Prevention of peri-procedural myocardial injury using a single high loading dose of rosuvastatin","volume":"24","author":"Cay","year":"2010","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ejim.2012.10.008_bb0055","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.amjcard.2009.04.048","article-title":"Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study","volume":"104","author":"Veselka","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2012.10.008_bb0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/BF02848771","article-title":"Does pravastatin therapy affect cardiac enzyme levels after percutaneous coronary intervention?","volume":"24","author":"Bozbas","year":"2007","journal-title":"Adv Ther"},{"key":"10.1016\/j.ejim.2012.10.008_bb0065","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/CIRCULATIONAHA.110.002451","article-title":"Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies","volume":"123","author":"Patti","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.10.008_bb0070","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00392-012-0490-9","article-title":"Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease","volume":"101","author":"Ndrepepa","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ejim.2012.10.008_bb0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.ejim.2012.10.008_bb0080","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","article-title":"A more meaningful scoring system for determining the severity of coronary heart disease","volume":"51","author":"Gensini","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2012.10.008_bb0085","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.10.008_bb0090","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCOUTCOMES.110.957951","article-title":"Landmark analysis at the 25-year landmark point","volume":"4","author":"Dafni","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ejim.2012.10.008_bb0095","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.103.15.1933","article-title":"Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels","volume":"103","author":"Jialal","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.10.008_bb0100","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1161\/01.CIR.99.25.3227","article-title":"Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial","volume":"99","author":"Dupuis","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.10.008_bb0105","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.jacc.2006.06.061","volume":"48","author":"Patti","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2012.10.008_bb0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/09537104.2010.512402","article-title":"Statins have an early antiplatelet effect in patients with acute myocardial infarction","volume":"22","author":"Matetzky","year":"2011","journal-title":"Platelets"},{"key":"10.1016\/j.ejim.2012.10.008_bb0115","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jcin.2011.02.005","article-title":"The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention","volume":"4","author":"Fujii","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejim.2012.10.008_bb0120","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.amjcard.2004.07.140","article-title":"Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury","volume":"94","author":"Mulukutla","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2012.10.008_bb0125","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2459\/01.JCM.0000228692.25205.86","article-title":"Protective role of chronic statin therapy in reducing myocardial damage during percutaneous coronary intervention","volume":"7","author":"Auguadro","year":"2006","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.ejim.2012.10.008_bb0130","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.amjcard.2012.06.052","article-title":"Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention","volume":"110","author":"Gordin","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2012.10.008_bb0135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1749-6632.2010.05725.x","article-title":"Protecting against ischemia\u2013reperfusion injury: antiplatelet drugs, statins, and their potential interactions","volume":"1207","author":"Ye","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ejim.2012.10.008_bb0140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.bjp.0706862","article-title":"Pretreatment with simvastatin reduces myocardial no-reflow by opening mitochondrial K(ATP) channel","volume":"149","author":"Zhao","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejim.2012.10.008_bb0145","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0735-1097(02)02816-4","article-title":"Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway","volume":"41","author":"Bell","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2012.10.008_bb0150","doi-asserted-by":"crossref","first-page":"e25320","DOI":"10.1371\/journal.pone.0025320","article-title":"Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction","volume":"6","author":"Tang","year":"2011","journal-title":"PLoS One"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620512002816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620512002816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T07:55:15Z","timestamp":1540108515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620512002816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0953620512002816"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2012.10.008","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}